Ruboxistaurin Completed Phase 3 Trials for Diabetes Mellitus, Noninsulin Dependent / Diabetic Neuropathies / Diabetes Mellitus, Insulin Dependent Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00044408Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
NCT00044395Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes